Definitions of Histological Abnormalities in Inflammatory Bowel Disease : an ECCO Position Paper
© The Author(s) 2023. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation..
Histological assessment of endoscopic biopsies in inflammatory bowel disease [IBD] plays an important role in clinical management, investigative studies, and clinical trials. Scoring schemes consisting of multiple histological items and offering considerable precision are widely available. However, definitions of histological abnormalities are often inconsistent. Furthermore, interobserver variability for their recognition and assessment may be high. The European Crohn's and Colitis Organisation [ECCO] formed an expert panel to explore definitions of histological abnormalities in IBD, with the aim of improving the quality of diagnosis and facilitating development of scoring schemes. The process confirmed that the current definitions often have no evidence base and vary between sources. Using available evidence and expert knowledge, the panel produced a series of ECCO consensus position statements on histological features in IBD.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
---|---|
Enthalten in: |
Journal of Crohn's & colitis - 18(2024), 2 vom: 26. Feb., Seite 175-191 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Feakins, Roger [VerfasserIn] |
---|
Links: |
---|
Themen: |
Crohn’s disease |
---|
Anmerkungen: |
Date Completed 28.02.2024 Date Revised 28.02.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/ecco-jcc/jjad142 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM361055749 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM361055749 | ||
003 | DE-627 | ||
005 | 20240229170230.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/ecco-jcc/jjad142 |2 doi | |
028 | 5 | 2 | |a pubmed24n1310.xml |
035 | |a (DE-627)NLM361055749 | ||
035 | |a (NLM)37607017 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Feakins, Roger |e verfasserin |4 aut | |
245 | 1 | 0 | |a Definitions of Histological Abnormalities in Inflammatory Bowel Disease |b an ECCO Position Paper |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.02.2024 | ||
500 | |a Date Revised 28.02.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2023. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. | ||
520 | |a Histological assessment of endoscopic biopsies in inflammatory bowel disease [IBD] plays an important role in clinical management, investigative studies, and clinical trials. Scoring schemes consisting of multiple histological items and offering considerable precision are widely available. However, definitions of histological abnormalities are often inconsistent. Furthermore, interobserver variability for their recognition and assessment may be high. The European Crohn's and Colitis Organisation [ECCO] formed an expert panel to explore definitions of histological abnormalities in IBD, with the aim of improving the quality of diagnosis and facilitating development of scoring schemes. The process confirmed that the current definitions often have no evidence base and vary between sources. Using available evidence and expert knowledge, the panel produced a series of ECCO consensus position statements on histological features in IBD | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Crohn’s disease | |
650 | 4 | |a Inflammatory bowel disease | |
650 | 4 | |a definition | |
650 | 4 | |a histology | |
650 | 4 | |a ulcerative colitis | |
700 | 1 | |a Borralho Nunes, Paula |e verfasserin |4 aut | |
700 | 1 | |a Driessen, Ann |e verfasserin |4 aut | |
700 | 1 | |a Gordon, Ilyssa O |e verfasserin |4 aut | |
700 | 1 | |a Zidar, Nina |e verfasserin |4 aut | |
700 | 1 | |a Baldin, Pamela |e verfasserin |4 aut | |
700 | 1 | |a Christensen, Britt |e verfasserin |4 aut | |
700 | 1 | |a Danese, Silvio |e verfasserin |4 aut | |
700 | 1 | |a Herlihy, Naoimh |e verfasserin |4 aut | |
700 | 1 | |a Iacucci, Marietta |e verfasserin |4 aut | |
700 | 1 | |a Loughrey, Maurice B |e verfasserin |4 aut | |
700 | 1 | |a Magro, Fernando |e verfasserin |4 aut | |
700 | 1 | |a Mookhoek, Aart |e verfasserin |4 aut | |
700 | 1 | |a Svrcek, Magali |e verfasserin |4 aut | |
700 | 1 | |a Rosini, Francesca |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of Crohn's & colitis |d 2007 |g 18(2024), 2 vom: 26. Feb., Seite 175-191 |w (DE-627)NLM204021901 |x 1876-4479 |7 nnns |
773 | 1 | 8 | |g volume:18 |g year:2024 |g number:2 |g day:26 |g month:02 |g pages:175-191 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/ecco-jcc/jjad142 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 18 |j 2024 |e 2 |b 26 |c 02 |h 175-191 |